| scholarly article | Q13442814 |
| P50 | author | Erin L Abner | Q60665975 |
| Gregory A Jicha | Q92594727 | ||
| Edward J Goetzl | Q97333667 | ||
| P2093 | author name string | Joel H Kramer | |
| Dimitrios Kapogiannis | |||
| Fanny M Elahi | |||
| Maja Mustapic | |||
| Omar Al-Janabi | |||
| P2860 | cites work | GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier | Q24309065 |
| Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q24595802 | ||
| Selective expression of the large neutral amino acid transporter at the blood-brain barrier | Q24672407 | ||
| Cerebrovascular disease in ageing and Alzheimer's disease | Q26771852 | ||
| Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria | Q29614408 | ||
| Healthy aging and dementia: findings from the Nun Study | Q30981106 | ||
| Alterations of the cerebral cortex in sporadic small vessel disease: A systematic review of in vivo MRI data | Q31038247 | ||
| Magnetic resonance imaging for assessment of cerebrovascular reactivity in cerebral small vessel disease: A systematic review | Q31046689 | ||
| Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis | Q31109560 | ||
| The biological function of the cellular prion protein: an update | Q33623592 | ||
| P-Glycoprotein, a gatekeeper in the blood-brain barrier | Q33904245 | ||
| Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease | Q34282454 | ||
| Small vessel disease and Alzheimer's dementia: pathological considerations | Q34568786 | ||
| Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study | Q35085348 | ||
| Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease | Q35850718 | ||
| Low neural exosomal levels of cellular survival factors in Alzheimer's disease | Q35935111 | ||
| Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer's disease-related microvascular cerebral amyloid angiopathy | Q36809375 | ||
| Shared genetic contribution to Ischaemic Stroke and Alzheimer's Disease | Q36895476 | ||
| Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects | Q37227424 | ||
| Physiological Functions of the Cellular Prion Protein. | Q37739095 | ||
| Brain infarction and the clinical expression of Alzheimer disease. The Nun Study | Q42435324 | ||
| Altered cargo proteins of human plasma endothelial cell-derived exosomes in atherosclerotic cerebrovascular disease. | Q45981443 | ||
| Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. | Q46675546 | ||
| Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease | Q48110929 | ||
| Small vessel disease is linked to disrupted structural network covariance in Alzheimer's disease | Q48333021 | ||
| Cerebral Perfusion Insufficiency and Relationships with Cognitive Deficits in Alzheimer's Disease: A Multiparametric Neuroimaging Study | Q49787280 | ||
| Prion protein is reduced in aging and in sporadic but not in familial Alzheimer's disease. | Q52846969 | ||
| Atherosclerosis of cerebral arteries in Alzheimer disease. | Q53264289 | ||
| Circle of Willis atherosclerosis: association with Alzheimer's disease, neuritic plaques and neurofibrillary tangles. | Q53281587 | ||
| The impact of cerebral amyloid angiopathy on the occurrence of cerebrovascular lesions in demented patients with Alzheimer features: a neuropathological study. | Q53316109 | ||
| Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1 - 42 and Hypertension | Q58597790 | ||
| "Liquid Biopsy" of White Matter Hyperintensity in Functionally Normal Elders | Q59335434 | ||
| Proteolytic shedding of the prion protein via activation of metallopeptidase ADAM10 reduces cellular binding and toxicity of amyloid-β oligomers | Q64093749 | ||
| Tau as a mediator of neurotoxicity associated to cerebral amyloid angiopathy | Q64098797 | ||
| Characterization of White Matter Hyperintensities in Large-Scale MRI-Studies | Q64118558 | ||
| Altered levels of plasma neuron-derived exosomes and their cargo proteins characterize acute and chronic mild traumatic brain injury | Q90863910 | ||
| Blood-Brain Barrier Leakage and Microvascular Lesions in Cerebral Amyloid Angiopathy | Q91128275 | ||
| Systematic and standardized comparison of reported amyloid-β receptors for sufficiency, affinity, and Alzheimer's disease relevance | Q91760283 | ||
| Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways | Q91892434 | ||
| Early Aβ reduction prevents progression of cerebral amyloid angiopathy | Q92270598 | ||
| Neuron-Derived Plasma Exosome Proteins after Remote Traumatic Brain Injury | Q92808634 | ||
| Amyloid β oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes | Q92916846 | ||
| P433 | issue | 4 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 5967-5974 | |
| P577 | publication date | 2020-03-10 | |
| P1433 | published in | FASEB Journal | Q520194 |
| P1476 | title | Endothelial-derived plasma exosome proteins in Alzheimer's disease angiopathy | |
| P478 | volume | 34 |
Search more.